In focus · trending topic

inflammatory bowel disease

32 stories · following the connections

Thetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease

By Nasdaq OMXNov 16, 2017, 5:35 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:28 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC